

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 5.47823517 |
| 2 | muscle hypertrophy in response to stress (GO:0003299) | 5.47823517 |
| 3 | cardiac muscle adaptation (GO:0014887) | 5.47823517 |
| 4 | * negative regulation of cytosolic calcium ion concentration (GO:0051481) | 5.17304747 |
| 5 | cardiac myofibril assembly (GO:0055003) | 4.94819064 |
| 6 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.86024584 |
| 7 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.60976141 |
| 8 | muscle hypertrophy (GO:0014896) | 4.48778754 |
| 9 | sarcomere organization (GO:0045214) | 4.48211008 |
| 10 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.45013911 |
| 11 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.43701144 |
| 12 | detection of light stimulus involved in visual perception (GO:0050908) | 4.43701144 |
| 13 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.36689937 |
| 14 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.33676646 |
| 15 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.31355520 |
| 16 | cardiac muscle contraction (GO:0060048) | 4.28543808 |
| 17 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.23181228 |
| 18 | myofibril assembly (GO:0030239) | 4.22675537 |
| 19 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.20001261 |
| 20 | striatum development (GO:0021756) | 4.12854797 |
| 21 | cell communication by electrical coupling (GO:0010644) | 4.09444298 |
| 22 | cellular ketone body metabolic process (GO:0046950) | 4.00544072 |
| 23 | cell communication involved in cardiac conduction (GO:0086065) | 3.96289053 |
| 24 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.95407128 |
| 25 | regulation of synapse structural plasticity (GO:0051823) | 3.89174528 |
| 26 | * regulation of membrane repolarization (GO:0060306) | 3.86684071 |
| 27 | inositol phosphate catabolic process (GO:0071545) | 3.75486649 |
| 28 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.70860371 |
| 29 | inositol phosphate dephosphorylation (GO:0046855) | 3.70860371 |
| 30 | epithelial cell fate commitment (GO:0072148) | 3.70573580 |
| 31 | cellular potassium ion homeostasis (GO:0030007) | 3.70509679 |
| 32 | retinal rod cell development (GO:0046548) | 3.65549162 |
| 33 | auditory receptor cell differentiation (GO:0042491) | 3.63275827 |
| 34 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.60032000 |
| 35 | regulation of cell communication by electrical coupling (GO:0010649) | 3.59462482 |
| 36 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.57478886 |
| 37 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.57318483 |
| 38 | sensory perception of smell (GO:0007608) | 3.52793377 |
| 39 | ketone body metabolic process (GO:1902224) | 3.49306185 |
| 40 | regulation of cardioblast differentiation (GO:0051890) | 3.48321736 |
| 41 | plasma membrane repair (GO:0001778) | 3.46861823 |
| 42 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.46175813 |
| 43 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.44815341 |
| 44 | insulin secretion (GO:0030073) | 3.43898874 |
| 45 | glycerophospholipid catabolic process (GO:0046475) | 3.43602221 |
| 46 | actin-myosin filament sliding (GO:0033275) | 3.42247955 |
| 47 | muscle filament sliding (GO:0030049) | 3.42247955 |
| 48 | sodium ion export (GO:0071436) | 3.39745944 |
| 49 | regulation of skeletal muscle contraction (GO:0014819) | 3.39608235 |
| 50 | striated muscle contraction (GO:0006941) | 3.31885939 |
| 51 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.31563242 |
| 52 | regulation of actin filament-based movement (GO:1903115) | 3.29597106 |
| 53 | regulation of sarcomere organization (GO:0060297) | 3.28728435 |
| 54 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.26513857 |
| 55 | detection of calcium ion (GO:0005513) | 3.26408730 |
| 56 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.25413505 |
| 57 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.24612984 |
| 58 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.23778273 |
| 59 | potassium ion import (GO:0010107) | 3.23401287 |
| 60 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.18849242 |
| 61 | regulation of relaxation of muscle (GO:1901077) | 3.17833431 |
| 62 | tricarboxylic acid cycle (GO:0006099) | 3.17749735 |
| 63 | regulation of the force of heart contraction (GO:0002026) | 3.16749261 |
| 64 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.16671854 |
| 65 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.15593575 |
| 66 | * regulation of heart rate by cardiac conduction (GO:0086091) | 3.14892691 |
| 67 | activation of protein kinase A activity (GO:0034199) | 3.13212345 |
| 68 | actomyosin structure organization (GO:0031032) | 3.12678564 |
| 69 | synaptic vesicle maturation (GO:0016188) | 3.11648562 |
| 70 | adult heart development (GO:0007512) | 3.07774590 |
| 71 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.07643913 |
| 72 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.07473728 |
| 73 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.07473728 |
| 74 | regulation of cardioblast proliferation (GO:0003264) | 3.06312635 |
| 75 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.06312635 |
| 76 | * cardiac conduction (GO:0061337) | 3.05373724 |
| 77 | membrane depolarization during action potential (GO:0086010) | 3.05165057 |
| 78 | * cardiac muscle cell action potential (GO:0086001) | 3.05135779 |
| 79 | membrane repolarization (GO:0086009) | 3.04919271 |
| 80 | cardiac muscle cell development (GO:0055013) | 3.04585676 |
| 81 | synaptic vesicle exocytosis (GO:0016079) | 3.02844095 |
| 82 | relaxation of smooth muscle (GO:0044557) | 3.00379415 |
| 83 | positive regulation of potassium ion transport (GO:0043268) | 2.99957693 |
| 84 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.99671064 |
| 85 | respiratory chain complex IV assembly (GO:0008535) | 2.98784309 |
| 86 | negative regulation of hormone metabolic process (GO:0032351) | 2.96162506 |
| 87 | striated muscle adaptation (GO:0014888) | 2.96028060 |
| 88 | actin-mediated cell contraction (GO:0070252) | 2.93866551 |
| 89 | * cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.93856360 |
| 90 | heart trabecula formation (GO:0060347) | 2.92582660 |
| 91 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.91337032 |
| 92 | cardiac cell development (GO:0055006) | 2.91120207 |
| 93 | cardiac muscle hypertrophy (GO:0003300) | 2.91093112 |
| 94 | * regulation of heart rate (GO:0002027) | 2.91001262 |
| 95 | response to inactivity (GO:0014854) | 2.90933055 |
| 96 | proline transport (GO:0015824) | 2.90914043 |
| 97 | urinary tract smooth muscle contraction (GO:0014848) | 2.90236397 |
| 98 | rhodopsin mediated signaling pathway (GO:0016056) | 2.90070172 |
| 99 | * potassium ion homeostasis (GO:0055075) | 2.89156426 |
| 100 | regulation of striated muscle contraction (GO:0006942) | 2.88944703 |
| 101 | cytochrome complex assembly (GO:0017004) | 2.88543226 |
| 102 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.87343698 |
| 103 | dentate gyrus development (GO:0021542) | 2.86889728 |
| 104 | relaxation of cardiac muscle (GO:0055119) | 2.86414590 |
| 105 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.85494339 |
| 106 | regulation of glucokinase activity (GO:0033131) | 2.82926983 |
| 107 | regulation of hexokinase activity (GO:1903299) | 2.82926983 |
| 108 | mating behavior (GO:0007617) | 2.80539969 |
| 109 | response to pheromone (GO:0019236) | 2.79761892 |
| 110 | regulation of cardiac muscle contraction (GO:0055117) | 2.79694885 |
| 111 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.79567645 |
| 112 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.78892639 |
| 113 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.78892639 |
| 114 | prepulse inhibition (GO:0060134) | 2.78067075 |
| 115 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.77841886 |
| 116 | cGMP biosynthetic process (GO:0006182) | 2.77374208 |
| 117 | muscle tissue morphogenesis (GO:0060415) | 2.76980462 |
| 118 | endocrine pancreas development (GO:0031018) | 2.76694844 |
| 119 | nitric oxide mediated signal transduction (GO:0007263) | 2.76155294 |
| 120 | striated muscle hypertrophy (GO:0014897) | 2.76049767 |
| 121 | response to caffeine (GO:0031000) | 2.75519221 |
| 122 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.74473932 |
| 123 | behavioral response to cocaine (GO:0048148) | 2.72748349 |
| 124 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.72259769 |
| 125 | retinal cone cell development (GO:0046549) | 2.72029829 |
| 126 | growth hormone secretion (GO:0030252) | 2.71319775 |
| 127 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.70561974 |
| 128 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.70512012 |
| 129 | protein localization to synapse (GO:0035418) | 2.70122155 |
| 130 | ventricular cardiac muscle cell development (GO:0055015) | 2.70038753 |
| 131 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.69618763 |
| 132 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.67978597 |
| 133 | synaptic transmission, dopaminergic (GO:0001963) | 2.67958524 |
| 134 | dendritic spine morphogenesis (GO:0060997) | 2.67506809 |
| 135 | peptide hormone processing (GO:0016486) | 2.66002381 |
| 136 | somite rostral/caudal axis specification (GO:0032525) | 2.65967034 |
| 137 | nephron tubule morphogenesis (GO:0072078) | 2.64952510 |
| 138 | nephron epithelium morphogenesis (GO:0072088) | 2.64952510 |
| 139 | regulation of execution phase of apoptosis (GO:1900117) | 2.63241717 |
| 140 | positive regulation of sodium ion transport (GO:0010765) | 2.63203447 |
| 141 | positive regulation of gluconeogenesis (GO:0045722) | 2.61584513 |
| 142 | renal tubule morphogenesis (GO:0061333) | 2.61128275 |
| 143 | polyol catabolic process (GO:0046174) | 2.60224745 |
| 144 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.57876569 |
| 145 | positive regulation of insulin secretion (GO:0032024) | 2.57835801 |
| 146 | positive regulation of neurotransmitter transport (GO:0051590) | 2.56690756 |
| 147 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.56397838 |
| 148 | adult feeding behavior (GO:0008343) | 2.54393652 |
| 149 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 2.51281406 |
| 150 | positive regulation of action potential (GO:0045760) | 2.50833779 |
| 151 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 2.45739709 |
| 152 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.44164617 |
| 153 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.44164617 |
| 154 | positive regulation of heart rate (GO:0010460) | 2.43742010 |
| 155 | regulation of neurotransmitter uptake (GO:0051580) | 2.43516967 |
| 156 | cardiac chamber formation (GO:0003207) | 2.43274589 |
| 157 | calcium ion import (GO:0070509) | 2.42605038 |
| 158 | muscle adaptation (GO:0043500) | 2.42566036 |
| 159 | positive regulation of heart growth (GO:0060421) | 2.41882831 |
| 160 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 2.40371006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.27163413 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.41592094 |
| 3 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.73159085 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.57549495 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.54952457 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.53706377 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.41267506 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.41267506 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.40600945 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.37823666 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35608010 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.32227780 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.30720367 |
| 14 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.29711136 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.28744443 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24573768 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.24081113 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20493694 |
| 19 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.19782989 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.14525102 |
| 21 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.11218475 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.07299570 |
| 23 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.00950990 |
| 24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.98851439 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98292835 |
| 26 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.89875627 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.88171418 |
| 28 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.86195269 |
| 29 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.80126984 |
| 30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.77904273 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.71062623 |
| 32 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.61055137 |
| 33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.56727236 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56651009 |
| 35 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.54960074 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50346407 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.50343443 |
| 38 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.48289200 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46390874 |
| 40 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.45513744 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44545151 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44507774 |
| 43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.44060048 |
| 44 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.43625296 |
| 45 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42337190 |
| 46 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.42201667 |
| 47 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.42201667 |
| 48 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.40636676 |
| 49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.37714632 |
| 50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.37527768 |
| 51 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.37129474 |
| 52 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.34695108 |
| 53 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.34617067 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33091852 |
| 55 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32328084 |
| 56 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.32196012 |
| 57 | TCF4_23295773_ChIP-Seq_U87_Human | 1.29956555 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29332984 |
| 59 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.28487290 |
| 60 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.28439750 |
| 61 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.27543759 |
| 62 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26465339 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24988075 |
| 64 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.24155104 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23824462 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.23553531 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.23527115 |
| 68 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.23333871 |
| 69 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22503001 |
| 70 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.21662567 |
| 71 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.21496379 |
| 72 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.21291646 |
| 73 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19960634 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.19053357 |
| 75 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.19032193 |
| 76 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18964540 |
| 77 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.18740063 |
| 78 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18581534 |
| 79 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.18177365 |
| 80 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17243583 |
| 81 | AR_19668381_ChIP-Seq_PC3_Human | 1.17116700 |
| 82 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16858923 |
| 83 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16094345 |
| 84 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16008265 |
| 85 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.15875079 |
| 86 | * GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15569890 |
| 87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15161484 |
| 88 | EWS_26573619_Chip-Seq_HEK293_Human | 1.14471861 |
| 89 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14198915 |
| 90 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.13773327 |
| 91 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.13664380 |
| 92 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.13498029 |
| 93 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.11256866 |
| 94 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.10909597 |
| 95 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.10885876 |
| 96 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.10783527 |
| 97 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.10553136 |
| 98 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.10493998 |
| 99 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.10430742 |
| 100 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.09651218 |
| 101 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.09651218 |
| 102 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09316637 |
| 103 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09246424 |
| 104 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.08876841 |
| 105 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07886359 |
| 106 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.07361743 |
| 107 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.06088113 |
| 108 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.05980961 |
| 109 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05539787 |
| 110 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05425254 |
| 111 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05298635 |
| 112 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04931036 |
| 113 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03980847 |
| 114 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.02917923 |
| 115 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.02917923 |
| 116 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02698380 |
| 117 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02045855 |
| 118 | TBL1_22424771_ChIP-Seq_293T_Human | 1.01917381 |
| 119 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01433391 |
| 120 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01398903 |
| 121 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00863828 |
| 122 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00187065 |
| 123 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98961871 |
| 124 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.98629769 |
| 125 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97608990 |
| 126 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.97210243 |
| 127 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96946754 |
| 128 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.95093772 |
| 129 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94477673 |
| 130 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93597676 |
| 131 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93458198 |
| 132 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93333526 |
| 133 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93277625 |
| 134 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93057791 |
| 135 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93001418 |
| 136 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92631594 |
| 137 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92427102 |
| 138 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.92379656 |
| 139 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92235005 |
| 140 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.91902480 |
| 141 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91300053 |
| 142 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89936829 |
| 143 | VDR_22108803_ChIP-Seq_LS180_Human | 0.89930143 |
| 144 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89236231 |
| 145 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88665608 |
| 146 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88607321 |
| 147 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87734408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.35366109 |
| 2 | MP0004215_abnormal_myocardial_fiber | 4.06350730 |
| 3 | MP0000751_myopathy | 3.88863332 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.85887331 |
| 5 | MP0001984_abnormal_olfaction | 3.51106248 |
| 6 | MP0002822_catalepsy | 3.34422478 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.26927401 |
| 8 | MP0003646_muscle_fatigue | 3.25326660 |
| 9 | MP0005551_abnormal_eye_electrophysiolog | 3.24733788 |
| 10 | MP0003195_calcinosis | 2.98933044 |
| 11 | MP0005379_endocrine/exocrine_gland_phen | 2.48602634 |
| 12 | MP0005330_cardiomyopathy | 2.48446976 |
| 13 | MP0003137_abnormal_impulse_conducting | 2.38985342 |
| 14 | MP0006054_spinal_hemorrhage | 2.38231484 |
| 15 | MP0006072_abnormal_retinal_apoptosis | 2.37677447 |
| 16 | MP0000749_muscle_degeneration | 2.35591835 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.32500708 |
| 18 | MP0008775_abnormal_heart_ventricle | 2.26112629 |
| 19 | MP0004145_abnormal_muscle_electrophysio | 2.17625231 |
| 20 | MP0004233_abnormal_muscle_weight | 2.11541622 |
| 21 | MP0004085_abnormal_heartbeat | 2.08820726 |
| 22 | MP0002972_abnormal_cardiac_muscle | 2.08299065 |
| 23 | MP0000013_abnormal_adipose_tissue | 2.08110094 |
| 24 | * MP0005620_abnormal_muscle_contractility | 2.07483675 |
| 25 | MP0003787_abnormal_imprinting | 2.00192243 |
| 26 | MP0004130_abnormal_muscle_cell | 1.94984185 |
| 27 | MP0002090_abnormal_vision | 1.93009428 |
| 28 | MP0004087_abnormal_muscle_fiber | 1.92754988 |
| 29 | MP0002163_abnormal_gland_morphology | 1.88717767 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.87074692 |
| 31 | MP0003880_abnormal_central_pattern | 1.85382695 |
| 32 | MP0005253_abnormal_eye_physiology | 1.84436318 |
| 33 | MP0001944_abnormal_pancreas_morphology | 1.82370719 |
| 34 | MP0010368_abnormal_lymphatic_system | 1.79396865 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.77022396 |
| 36 | MP0002693_abnormal_pancreas_physiology | 1.74580101 |
| 37 | MP0004859_abnormal_synaptic_plasticity | 1.70787395 |
| 38 | MP0004270_analgesia | 1.68669437 |
| 39 | MP0005670_abnormal_white_adipose | 1.66960917 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.61556805 |
| 41 | MP0001544_abnormal_cardiovascular_syste | 1.58223905 |
| 42 | MP0005385_cardiovascular_system_phenoty | 1.58223905 |
| 43 | * MP0003635_abnormal_synaptic_transmissio | 1.57427777 |
| 44 | MP0004484_altered_response_of | 1.55379186 |
| 45 | MP0002106_abnormal_muscle_physiology | 1.53497928 |
| 46 | MP0008877_abnormal_DNA_methylation | 1.50185612 |
| 47 | MP0010630_abnormal_cardiac_muscle | 1.50097002 |
| 48 | MP0005423_abnormal_somatic_nervous | 1.47954228 |
| 49 | MP0006138_congestive_heart_failure | 1.47820601 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.46511160 |
| 51 | MP0001486_abnormal_startle_reflex | 1.45017165 |
| 52 | MP0002254_reproductive_system_inflammat | 1.44098564 |
| 53 | MP0000750_abnormal_muscle_regeneration | 1.41002548 |
| 54 | MP0002269_muscular_atrophy | 1.40855811 |
| 55 | MP0005646_abnormal_pituitary_gland | 1.40424992 |
| 56 | MP0000003_abnormal_adipose_tissue | 1.39377126 |
| 57 | MP0002127_abnormal_cardiovascular_syste | 1.36979449 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 1.35775934 |
| 59 | MP0002638_abnormal_pupillary_reflex | 1.34265628 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.33741137 |
| 61 | MP0000747_muscle_weakness | 1.32575054 |
| 62 | MP0009745_abnormal_behavioral_response | 1.31059489 |
| 63 | MP0001661_extended_life_span | 1.28519202 |
| 64 | MP0005369_muscle_phenotype | 1.27515307 |
| 65 | MP0000759_abnormal_skeletal_muscle | 1.27164915 |
| 66 | MP0002063_abnormal_learning/memory/cond | 1.27135609 |
| 67 | MP0003283_abnormal_digestive_organ | 1.26734288 |
| 68 | MP0001529_abnormal_vocalization | 1.26120135 |
| 69 | MP0005195_abnormal_posterior_eye | 1.25973364 |
| 70 | MP0003011_delayed_dark_adaptation | 1.24959055 |
| 71 | MP0002876_abnormal_thyroid_physiology | 1.24563943 |
| 72 | MP0002064_seizures | 1.24490820 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 1.24291569 |
| 74 | * MP0002272_abnormal_nervous_system | 1.22656261 |
| 75 | MP0004510_myositis | 1.22431345 |
| 76 | MP0005084_abnormal_gallbladder_morpholo | 1.18776519 |
| 77 | MP0005394_taste/olfaction_phenotype | 1.15140909 |
| 78 | MP0005499_abnormal_olfactory_system | 1.15140909 |
| 79 | MP0002734_abnormal_mechanical_nocicepti | 1.15096005 |
| 80 | MP0000372_irregular_coat_pigmentation | 1.12484946 |
| 81 | MP0005375_adipose_tissue_phenotype | 1.12224217 |
| 82 | MP0009046_muscle_twitch | 1.11785872 |
| 83 | MP0004924_abnormal_behavior | 1.11448618 |
| 84 | MP0005386_behavior/neurological_phenoty | 1.11448618 |
| 85 | MP0005623_abnormal_meninges_morphology | 1.09828888 |
| 86 | MP0004885_abnormal_endolymph | 1.09630693 |
| 87 | MP0001879_abnormal_lymphatic_vessel | 1.06017989 |
| 88 | MP0002184_abnormal_innervation | 1.05259820 |
| 89 | MP0002572_abnormal_emotion/affect_behav | 1.04158910 |
| 90 | MP0002234_abnormal_pharynx_morphology | 1.03082890 |
| 91 | MP0003122_maternal_imprinting | 1.01944022 |
| 92 | MP0005332_abnormal_amino_acid | 1.01711859 |
| 93 | MP0005666_abnormal_adipose_tissue | 1.01642259 |
| 94 | MP0001905_abnormal_dopamine_level | 1.00168939 |
| 95 | MP0003121_genomic_imprinting | 1.00117738 |
| 96 | MP0001756_abnormal_urination | 0.98995960 |
| 97 | MP0002229_neurodegeneration | 0.98948359 |
| 98 | MP0001968_abnormal_touch/_nociception | 0.98760231 |
| 99 | MP0003123_paternal_imprinting | 0.98439458 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.98164958 |
| 101 | MP0002733_abnormal_thermal_nociception | 0.97611761 |
| 102 | MP0005448_abnormal_energy_balance | 0.96042806 |
| 103 | MP0004272_abnormal_basement_membrane | 0.95796687 |
| 104 | MP0002752_abnormal_somatic_nervous | 0.94356678 |
| 105 | MP0010329_abnormal_lipoprotein_level | 0.94199035 |
| 106 | MP0002067_abnormal_sensory_capabilities | 0.93764539 |
| 107 | MP0003221_abnormal_cardiomyocyte_apopto | 0.93389437 |
| 108 | MP0000230_abnormal_systemic_arterial | 0.92715106 |
| 109 | MP0005367_renal/urinary_system_phenotyp | 0.92573958 |
| 110 | MP0000516_abnormal_urinary_system | 0.92573958 |
| 111 | MP0008789_abnormal_olfactory_epithelium | 0.92060745 |
| 112 | MP0005645_abnormal_hypothalamus_physiol | 0.91000203 |
| 113 | MP0002882_abnormal_neuron_morphology | 0.87858953 |
| 114 | MP0002295_abnormal_pulmonary_circulatio | 0.86572068 |
| 115 | MP0003828_pulmonary_edema | 0.86469517 |
| 116 | MP0005167_abnormal_blood-brain_barrier | 0.86088850 |
| 117 | MP0009780_abnormal_chondrocyte_physiolo | 0.85770001 |
| 118 | MP0001501_abnormal_sleep_pattern | 0.84774807 |
| 119 | MP0004043_abnormal_pH_regulation | 0.83159884 |
| 120 | MP0004142_abnormal_muscle_tone | 0.83079983 |
| 121 | MP0003953_abnormal_hormone_level | 0.81522851 |
| 122 | MP0004019_abnormal_vitamin_homeostasis | 0.78724578 |
| 123 | MP0000631_abnormal_neuroendocrine_gland | 0.78478422 |
| 124 | MP0006036_abnormal_mitochondrial_physio | 0.77057615 |
| 125 | MP0002557_abnormal_social/conspecific_i | 0.75818578 |
| 126 | MP0008569_lethality_at_weaning | 0.75101554 |
| 127 | MP0002108_abnormal_muscle_morphology | 0.75089184 |
| 128 | MP0005248_abnormal_Harderian_gland | 0.74708331 |
| 129 | MP0003279_aneurysm | 0.74459799 |
| 130 | MP0005165_increased_susceptibility_to | 0.72746490 |
| 131 | MP0010386_abnormal_urinary_bladder | 0.72326408 |
| 132 | MP0006276_abnormal_autonomic_nervous | 0.69585927 |
| 133 | MP0000266_abnormal_heart_morphology | 0.67109992 |
| 134 | MP0003633_abnormal_nervous_system | 0.66692764 |
| 135 | * MP0005595_abnormal_vascular_smooth | 0.66490644 |
| 136 | MP0005535_abnormal_body_temperature | 0.65838141 |
| 137 | MP0001970_abnormal_pain_threshold | 0.64734144 |
| 138 | MP0003879_abnormal_hair_cell | 0.64215254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 7.48784354 |
| 2 | Central scotoma (HP:0000603) | 6.19768940 |
| 3 | Sudden death (HP:0001699) | 5.71613641 |
| 4 | * Atrial fibrillation (HP:0005110) | 5.00315710 |
| 5 | Exercise-induced myalgia (HP:0003738) | 4.87562902 |
| 6 | Congenital malformation of the right heart (HP:0011723) | 4.78699590 |
| 7 | Double outlet right ventricle (HP:0001719) | 4.78699590 |
| 8 | * Primary atrial arrhythmia (HP:0001692) | 4.76559637 |
| 9 | Scotoma (HP:0000575) | 4.65239097 |
| 10 | Abnormality of macular pigmentation (HP:0008002) | 4.60162815 |
| 11 | * Supraventricular tachycardia (HP:0004755) | 4.54947186 |
| 12 | * Supraventricular arrhythmia (HP:0005115) | 4.51090021 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 4.47035504 |
| 14 | * Prolonged QT interval (HP:0001657) | 4.43759326 |
| 15 | Calf muscle hypertrophy (HP:0008981) | 4.35796576 |
| 16 | Syncope (HP:0001279) | 4.35244341 |
| 17 | Ventricular tachycardia (HP:0004756) | 4.34758209 |
| 18 | Muscle fiber splitting (HP:0003555) | 4.08539928 |
| 19 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.00128923 |
| 20 | Abnormality of the calf musculature (HP:0001430) | 3.96135341 |
| 21 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.80609109 |
| 22 | Ventricular fibrillation (HP:0001663) | 3.65500577 |
| 23 | Hypoglycemic coma (HP:0001325) | 3.65174569 |
| 24 | Severe visual impairment (HP:0001141) | 3.62759639 |
| 25 | Myoglobinuria (HP:0002913) | 3.59730842 |
| 26 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.58613647 |
| 27 | Lipoatrophy (HP:0100578) | 3.51459407 |
| 28 | * Abnormal EKG (HP:0003115) | 3.40881539 |
| 29 | Hyporeflexia of lower limbs (HP:0002600) | 3.32498376 |
| 30 | Hyperglycemia (HP:0003074) | 3.27163591 |
| 31 | Bundle branch block (HP:0011710) | 3.09439515 |
| 32 | Left ventricular hypertrophy (HP:0001712) | 3.07895921 |
| 33 | Ventricular arrhythmia (HP:0004308) | 3.06752195 |
| 34 | * Palpitations (HP:0001962) | 3.03700974 |
| 35 | Dilated cardiomyopathy (HP:0001644) | 3.02187837 |
| 36 | Abnormality of vitamin B metabolism (HP:0004340) | 3.00659087 |
| 37 | Abnormal pancreas size (HP:0012094) | 2.99679409 |
| 38 | EMG: myopathic abnormalities (HP:0003458) | 2.94007163 |
| 39 | Hemiparesis (HP:0001269) | 2.93518837 |
| 40 | Hypothermia (HP:0002045) | 2.91864039 |
| 41 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.90767811 |
| 42 | Methylmalonic acidemia (HP:0002912) | 2.84620017 |
| 43 | Decreased central vision (HP:0007663) | 2.84319330 |
| 44 | Right ventricular cardiomyopathy (HP:0011663) | 2.81960921 |
| 45 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.80732006 |
| 46 | Hypoglycemic seizures (HP:0002173) | 2.78253849 |
| 47 | Heart block (HP:0012722) | 2.75528899 |
| 48 | Increased CSF protein (HP:0002922) | 2.74730914 |
| 49 | Myokymia (HP:0002411) | 2.74712757 |
| 50 | Difficulty running (HP:0009046) | 2.74145322 |
| 51 | Myotonia (HP:0002486) | 2.72653201 |
| 52 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.71058102 |
| 53 | Subaortic stenosis (HP:0001682) | 2.71058102 |
| 54 | Vascular calcification (HP:0004934) | 2.69107229 |
| 55 | Enlarged penis (HP:0000040) | 2.65711352 |
| 56 | Atrioventricular block (HP:0001678) | 2.65290863 |
| 57 | Pigmentary retinal degeneration (HP:0001146) | 2.64849800 |
| 58 | Increased circulating renin level (HP:0000848) | 2.63362524 |
| 59 | Abnormality of vitamin metabolism (HP:0100508) | 2.58315777 |
| 60 | Abnormality of urine glucose concentration (HP:0011016) | 2.54999718 |
| 61 | Glycosuria (HP:0003076) | 2.54999718 |
| 62 | Abnormal atrioventricular conduction (HP:0005150) | 2.53331353 |
| 63 | Intestinal atresia (HP:0011100) | 2.53225161 |
| 64 | Keratoconus (HP:0000563) | 2.48760556 |
| 65 | Increased corneal curvature (HP:0100692) | 2.48760556 |
| 66 | Late onset (HP:0003584) | 2.47026487 |
| 67 | Hypomagnesemia (HP:0002917) | 2.46949277 |
| 68 | Increased variability in muscle fiber diameter (HP:0003557) | 2.45300100 |
| 69 | Abolished electroretinogram (ERG) (HP:0000550) | 2.40481576 |
| 70 | Chorioretinal atrophy (HP:0000533) | 2.38035563 |
| 71 | Febrile seizures (HP:0002373) | 2.36379783 |
| 72 | Proximal tubulopathy (HP:0000114) | 2.36058878 |
| 73 | Pheochromocytoma (HP:0002666) | 2.35722970 |
| 74 | Methylmalonic aciduria (HP:0012120) | 2.35568545 |
| 75 | Asymmetric septal hypertrophy (HP:0001670) | 2.34500514 |
| 76 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.31475798 |
| 77 | Prominent supraorbital ridges (HP:0000336) | 2.31118545 |
| 78 | Ketosis (HP:0001946) | 2.30791116 |
| 79 | Increased connective tissue (HP:0009025) | 2.28179673 |
| 80 | Cardiovascular calcification (HP:0011915) | 2.27246872 |
| 81 | Polyphagia (HP:0002591) | 2.26597130 |
| 82 | Absence seizures (HP:0002121) | 2.22988229 |
| 83 | Agitation (HP:0000713) | 2.22330817 |
| 84 | Neuroendocrine neoplasm (HP:0100634) | 2.20223892 |
| 85 | Hepatic necrosis (HP:0002605) | 2.20081578 |
| 86 | Postural tremor (HP:0002174) | 2.19965691 |
| 87 | Visual hallucinations (HP:0002367) | 2.17359503 |
| 88 | Epileptic encephalopathy (HP:0200134) | 2.16955441 |
| 89 | Muscle stiffness (HP:0003552) | 2.16404627 |
| 90 | Polydipsia (HP:0001959) | 2.15041975 |
| 91 | Abnormal drinking behavior (HP:0030082) | 2.15041975 |
| 92 | Rhabdomyolysis (HP:0003201) | 2.11370525 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.09488516 |
| 94 | Dicarboxylic aciduria (HP:0003215) | 2.09488516 |
| 95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.07003646 |
| 96 | Difficulty climbing stairs (HP:0003551) | 2.05284354 |
| 97 | Testicular neoplasm (HP:0010788) | 2.05249291 |
| 98 | Anxiety (HP:0000739) | 2.03202267 |
| 99 | Dysmetric saccades (HP:0000641) | 2.02809653 |
| 100 | Dyschromatopsia (HP:0007641) | 2.02648467 |
| 101 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.02449292 |
| 102 | Pendular nystagmus (HP:0012043) | 2.01434492 |
| 103 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.00522935 |
| 104 | Hypoplasia of the fovea (HP:0007750) | 1.98683884 |
| 105 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.98683884 |
| 106 | Focal motor seizures (HP:0011153) | 1.98393344 |
| 107 | Depression (HP:0000716) | 1.97539401 |
| 108 | Tongue fasciculations (HP:0001308) | 1.96213289 |
| 109 | Attenuation of retinal blood vessels (HP:0007843) | 1.95195310 |
| 110 | Hematochezia (HP:0002573) | 1.94916640 |
| 111 | Hyperventilation (HP:0002883) | 1.92671704 |
| 112 | Ketoacidosis (HP:0001993) | 1.92499496 |
| 113 | Muscle fibrillation (HP:0010546) | 1.89792583 |
| 114 | Atonic seizures (HP:0010819) | 1.89028947 |
| 115 | Renal cortical cysts (HP:0000803) | 1.88901956 |
| 116 | Mitochondrial inheritance (HP:0001427) | 1.88589464 |
| 117 | Abnormality of magnesium homeostasis (HP:0004921) | 1.87499614 |
| 118 | Acute necrotizing encephalopathy (HP:0006965) | 1.86458128 |
| 119 | Large for gestational age (HP:0001520) | 1.85087846 |
| 120 | Athetosis (HP:0002305) | 1.84792911 |
| 121 | Hypoplastic left heart (HP:0004383) | 1.84494050 |
| 122 | EEG with generalized epileptiform discharges (HP:0011198) | 1.83601421 |
| 123 | Abnormality of renal excretion (HP:0011036) | 1.83147050 |
| 124 | Gaze-evoked nystagmus (HP:0000640) | 1.83056249 |
| 125 | Hyperphosphatemia (HP:0002905) | 1.82511181 |
| 126 | Limb-girdle muscle atrophy (HP:0003797) | 1.82467398 |
| 127 | Neoplasm of the adrenal gland (HP:0100631) | 1.82217247 |
| 128 | Epileptiform EEG discharges (HP:0011182) | 1.80799351 |
| 129 | Fetal akinesia sequence (HP:0001989) | 1.80334179 |
| 130 | Medial flaring of the eyebrow (HP:0010747) | 1.78517316 |
| 131 | Polyuria (HP:0000103) | 1.78216398 |
| 132 | Truncus arteriosus (HP:0001660) | 1.77525657 |
| 133 | Optic disc pallor (HP:0000543) | 1.76972823 |
| 134 | Hamartoma of the eye (HP:0010568) | 1.76062487 |
| 135 | Abnormality of the renal cortex (HP:0011035) | 1.75958486 |
| 136 | Bradycardia (HP:0001662) | 1.75757544 |
| 137 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.74218236 |
| 138 | Type 1 muscle fiber predominance (HP:0003803) | 1.74070139 |
| 139 | Rimmed vacuoles (HP:0003805) | 1.73394428 |
| 140 | Abnormality of the foot musculature (HP:0001436) | 1.72857971 |
| 141 | Poor suck (HP:0002033) | 1.72103196 |
| 142 | Dialeptic seizures (HP:0011146) | 1.71469291 |
| 143 | Type II diabetes mellitus (HP:0005978) | 1.69335229 |
| 144 | Dysdiadochokinesis (HP:0002075) | 1.68863220 |
| 145 | Focal seizures (HP:0007359) | 1.68504080 |
| 146 | Retinal dysplasia (HP:0007973) | 1.66627716 |
| 147 | Foot dorsiflexor weakness (HP:0009027) | 1.66579888 |
| 148 | Generalized tonic-clonic seizures (HP:0002069) | 1.66573473 |
| 149 | Progressive macrocephaly (HP:0004481) | 1.65673722 |
| 150 | Muscular dystrophy (HP:0003560) | 1.65578000 |
| 151 | Torticollis (HP:0000473) | 1.63550470 |
| 152 | Rapidly progressive (HP:0003678) | 1.60180187 |
| 153 | Lower limb amyotrophy (HP:0007210) | 1.59656868 |
| 154 | Abnormality of the vocal cords (HP:0008777) | 1.54961405 |
| 155 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.53983408 |
| 156 | Broad metatarsal (HP:0001783) | 1.52830778 |
| 157 | Ragged-red muscle fibers (HP:0003200) | 1.51987092 |
| 158 | Palmoplantar keratoderma (HP:0000982) | 1.51935352 |
| 159 | Distal lower limb amyotrophy (HP:0008944) | 1.51520022 |
| 160 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.50721834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.52915046 |
| 2 | PHKG1 | 3.96082463 |
| 3 | PHKG2 | 3.96082463 |
| 4 | TTN | 3.47463992 |
| 5 | MAP4K2 | 3.14521946 |
| 6 | MYLK | 3.00749727 |
| 7 | LMTK2 | 2.86915642 |
| 8 | EPHA4 | 2.72476910 |
| 9 | TIE1 | 2.54721880 |
| 10 | RIPK1 | 2.44369589 |
| 11 | FGFR2 | 2.38204402 |
| 12 | OBSCN | 2.36346268 |
| 13 | NEK1 | 2.13455095 |
| 14 | DMPK | 2.06667106 |
| 15 | PAK6 | 1.99206264 |
| 16 | PINK1 | 1.97481309 |
| 17 | TNIK | 1.92707711 |
| 18 | MST4 | 1.87973088 |
| 19 | CAMK2D | 1.77148010 |
| 20 | TRPM7 | 1.70451243 |
| 21 | PAK3 | 1.69165607 |
| 22 | PRKD3 | 1.64215730 |
| 23 | BMPR1B | 1.52484696 |
| 24 | NLK | 1.44484818 |
| 25 | TRIB3 | 1.41395069 |
| 26 | ERBB3 | 1.41343757 |
| 27 | PRPF4B | 1.37706010 |
| 28 | MAP3K4 | 1.36487542 |
| 29 | BCKDK | 1.33186119 |
| 30 | PKN2 | 1.32545765 |
| 31 | CASK | 1.27048708 |
| 32 | PDK3 | 1.25750058 |
| 33 | PDK4 | 1.25750058 |
| 34 | PRKG2 | 1.25337843 |
| 35 | STK38 | 1.21683005 |
| 36 | MINK1 | 1.20727614 |
| 37 | MUSK | 1.19038641 |
| 38 | CAMKK1 | 1.18245455 |
| 39 | CAMK1G | 1.17388325 |
| 40 | FGFR3 | 1.17369213 |
| 41 | NTRK3 | 1.17316803 |
| 42 | GRK1 | 1.17288838 |
| 43 | MAP2K6 | 1.16612704 |
| 44 | INSRR | 1.15346421 |
| 45 | MAP3K9 | 1.12962898 |
| 46 | MAP3K7 | 1.08930065 |
| 47 | CAMK1 | 1.08556356 |
| 48 | STK39 | 1.07286760 |
| 49 | MARK1 | 1.06808668 |
| 50 | KSR2 | 1.05780225 |
| 51 | PRKD1 | 1.03613270 |
| 52 | CAMK1D | 1.03064108 |
| 53 | CDC42BPA | 1.02751779 |
| 54 | CAMK2A | 1.02560662 |
| 55 | KSR1 | 1.01909400 |
| 56 | PRKAA1 | 1.01702860 |
| 57 | PLK2 | 1.00118321 |
| 58 | ADRBK2 | 0.95425352 |
| 59 | MAP3K12 | 0.94487064 |
| 60 | NTRK2 | 0.93606012 |
| 61 | OXSR1 | 0.93130569 |
| 62 | ROCK1 | 0.92030985 |
| 63 | PIK3CA | 0.90831315 |
| 64 | SGK223 | 0.90062223 |
| 65 | SGK494 | 0.90062223 |
| 66 | ARAF | 0.89668458 |
| 67 | ACVR1B | 0.89083963 |
| 68 | CSNK1G1 | 0.88580740 |
| 69 | PKN1 | 0.88250103 |
| 70 | LIMK1 | 0.87661905 |
| 71 | PRKCG | 0.87381141 |
| 72 | CAMK2G | 0.85550912 |
| 73 | GRK7 | 0.83906831 |
| 74 | TAF1 | 0.82447736 |
| 75 | ROCK2 | 0.81872254 |
| 76 | PRKCH | 0.81846167 |
| 77 | FER | 0.79639135 |
| 78 | KDR | 0.79261403 |
| 79 | PTK2B | 0.78568976 |
| 80 | CAMK2B | 0.77869495 |
| 81 | PRKAA2 | 0.77143846 |
| 82 | MARK2 | 0.76837373 |
| 83 | CAMKK2 | 0.76704539 |
| 84 | CAMK4 | 0.75779519 |
| 85 | CDK5 | 0.75401570 |
| 86 | EPHB2 | 0.74785878 |
| 87 | WNK1 | 0.74395732 |
| 88 | MAPK13 | 0.74027005 |
| 89 | MAPK12 | 0.73558850 |
| 90 | DAPK2 | 0.72796394 |
| 91 | STK38L | 0.72440252 |
| 92 | STK16 | 0.71810617 |
| 93 | TAOK1 | 0.70633444 |
| 94 | PDK2 | 0.70037195 |
| 95 | MAPK15 | 0.69550998 |
| 96 | WNK3 | 0.65925437 |
| 97 | SIK2 | 0.65630819 |
| 98 | PRKCE | 0.64062952 |
| 99 | MAP2K4 | 0.63971707 |
| 100 | WNK4 | 0.63513918 |
| 101 | FLT3 | 0.62478212 |
| 102 | STK24 | 0.59650195 |
| 103 | DAPK3 | 0.59160686 |
| 104 | DYRK1A | 0.58826612 |
| 105 | ILK | 0.58661707 |
| 106 | PRKD2 | 0.57716556 |
| 107 | SGK2 | 0.56857991 |
| 108 | CSNK1G2 | 0.56238260 |
| 109 | MAP3K13 | 0.56083144 |
| 110 | NUAK1 | 0.55450330 |
| 111 | PRKACA | 0.55006853 |
| 112 | PNCK | 0.54836740 |
| 113 | PRKCQ | 0.54593007 |
| 114 | UHMK1 | 0.53488149 |
| 115 | STK11 | 0.52158585 |
| 116 | NTRK1 | 0.51716414 |
| 117 | CSNK1G3 | 0.51495501 |
| 118 | STK3 | 0.51353622 |
| 119 | PDGFRA | 0.50319627 |
| 120 | SGK1 | 0.50219302 |
| 121 | SGK3 | 0.50190376 |
| 122 | ZAK | 0.48537222 |
| 123 | PRKACG | 0.47232188 |
| 124 | RPS6KA3 | 0.46180267 |
| 125 | FES | 0.45823561 |
| 126 | GRK5 | 0.44721910 |
| 127 | PRKG1 | 0.44357183 |
| 128 | NME1 | 0.44138311 |
| 129 | MAP3K1 | 0.44012737 |
| 130 | ICK | 0.43836257 |
| 131 | IRAK2 | 0.43515267 |
| 132 | MAP2K7 | 0.42830863 |
| 133 | PRKACB | 0.41878828 |
| 134 | TNK2 | 0.41801170 |
| 135 | PRKCI | 0.41349285 |
| 136 | RAF1 | 0.40761621 |
| 137 | EPHA3 | 0.36736508 |
| 138 | PRKCZ | 0.36436896 |
| 139 | ADRBK1 | 0.34810960 |
| 140 | HIPK2 | 0.33222238 |
| 141 | IRAK1 | 0.32975065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.40109639 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.39184053 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 3.25192687 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.07919617 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.79041371 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.77481246 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.42696629 |
| 8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.41914728 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.32281166 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.24240789 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 2.17454288 |
| 12 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.05903149 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.03580086 |
| 14 | Nicotine addiction_Homo sapiens_hsa05033 | 1.96601342 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.95537969 |
| 16 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.92348842 |
| 17 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.92204560 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.90597629 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.83640690 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.72243140 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.69777047 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.65994629 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58788671 |
| 24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.51997025 |
| 25 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.50635343 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.50419468 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.48422727 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.47704620 |
| 29 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.45767734 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.45237607 |
| 31 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.44688049 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.40501274 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.33659977 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33436860 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.33153732 |
| 36 | Circadian rhythm_Homo sapiens_hsa04710 | 1.31516747 |
| 37 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.30631851 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.30605573 |
| 39 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.26792557 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.26565224 |
| 41 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.26104383 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25934457 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24114541 |
| 44 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.22975143 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.20422286 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.17916338 |
| 47 | Taste transduction_Homo sapiens_hsa04742 | 1.14430004 |
| 48 | Cocaine addiction_Homo sapiens_hsa05030 | 1.13784462 |
| 49 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.11590650 |
| 50 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.11476058 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04922281 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.04459746 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.98680809 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98153510 |
| 55 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.96464016 |
| 56 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.94787908 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94231466 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.93488600 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92585368 |
| 60 | Long-term potentiation_Homo sapiens_hsa04720 | 0.92538265 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.91546220 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91486992 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.90143273 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.89065136 |
| 65 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86934030 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85664499 |
| 67 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.85216340 |
| 68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81148126 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80701703 |
| 70 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.76664470 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.76272032 |
| 72 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.74397928 |
| 73 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.73819490 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72545638 |
| 75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72380545 |
| 76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71117622 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70649744 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.69972657 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69825410 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66377364 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66153717 |
| 82 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65861993 |
| 83 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64053342 |
| 84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64012206 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63283329 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62854461 |
| 87 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62762489 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62666934 |
| 89 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61620785 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61448250 |
| 91 | Long-term depression_Homo sapiens_hsa04730 | 0.60749678 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60495274 |
| 93 | Melanogenesis_Homo sapiens_hsa04916 | 0.58316654 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57933000 |
| 95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56723222 |
| 96 | Axon guidance_Homo sapiens_hsa04360 | 0.56160614 |
| 97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56097659 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55877052 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55502545 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.54012636 |
| 101 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.53456811 |
| 102 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52762498 |
| 103 | Tight junction_Homo sapiens_hsa04530 | 0.52363183 |
| 104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51789225 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51532064 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48139283 |
| 107 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48106656 |
| 108 | Bile secretion_Homo sapiens_hsa04976 | 0.47336480 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47259456 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46738535 |
| 111 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.46632455 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44262485 |
| 113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43943505 |
| 114 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43474266 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42839319 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42423717 |
| 117 | Focal adhesion_Homo sapiens_hsa04510 | 0.42169371 |
| 118 | Viral myocarditis_Homo sapiens_hsa05416 | 0.41759790 |
| 119 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.41221449 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.41198786 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40333126 |
| 122 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39832314 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38481712 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38112388 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37839522 |
| 126 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.36693192 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.36456523 |
| 128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36315399 |
| 129 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35757311 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34537557 |
| 131 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.32487617 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31776750 |
| 133 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.29823562 |
| 134 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.29290108 |

